Biomarkers for Immunotherapy of Cancer: Methods and Protocols
This book provides the immune oncology (IO) community with a deeper understanding of the scope of the biomarker methods to potentially improve the outcome from immunotherapy. The editors secured the input from experts in the field dedicated to translating scientific research from bench to bedside wa...
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
New York, NY
Springer New York
2020
|
Ausgabe: | 1st ed. 2020 |
Schriftenreihe: | Methods in Molecular Biology
2055 |
Schlagworte: | |
Online-Zugang: | UBR01 TUM01 Volltext |
Zusammenfassung: | This book provides the immune oncology (IO) community with a deeper understanding of the scope of the biomarker methods to potentially improve the outcome from immunotherapy. The editors secured the input from experts in the field dedicated to translating scientific research from bench to bedside was submitted. The book provides not only details about the technical, standardization and interpretation aspects of the methods but also introduces the reader to the background information and scientific justification for selected biomarkers and assays. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls |
Beschreibung: | Status of Immune-oncology: Challenges and Opportunities -- Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors -- Measuring Tumor Mutational Burden Using Whole Exome Sequencing -- Germline Genetics in Immuno-Oncology: From Genome-wide to Targeted Biomarker Strategies -- Detection of Microsatellite Instability Biomarkers via Next-generation Sequencing -- Genetic Instability Markers in Cancer -- Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma -- Techniques Associated with Exosome Isolation for Biomarker Development - Liquid Biopsies for Ovarian Cancer Detection -- Identifying MicroRNA Pathway Variants as Biomarkers of Patient Selection for Immune Therapy -- Histone Modifications as Biomarkers for Immunotherapy -- Functional Genome Profiling to Understand Cancer Immune Responsiveness -- Using RNA-sequencing to Characterize the Tumor Microenvironment -- - Development of Gene Expression Based Biomarkers on the nCounter Platform for Immuno-Oncology Applications -- The CRISPR System and Cancer Immunotherapy Biomarkers -- HLA Class I Antigen Processing Machinery Defects in Cancer Cells - Frequency, Functional Significance and Clinical Relevance with Special Emphasis on their Role in T cell-based Immunotherapy of Malignant Disease -- High-parameter Immune Profiling with CyTOF -- The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy -- Single Molecule Arrays for Ultrasensitive Detection of Blood-based Biomarkers for Immunotherapy -- Single-cell Multiplexed Proteomics on the IsoLight Resolves Cellular Functional Heterogeneity to Reveal Clinical Responses of Cancer Patients to Immunotherapies -- Methods to Detect Immunogenic Cell Death in vivo -- Overview of Tissue Imaging Methods -- Multiplex Immunofluorescence Assays -- - Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis -- Cyclic Multiplexed-Immunofluorescence (cmIF), A Highly Multiplexed Method for Single-cell Analysis -- High-Plex Spatially Resolved RNA and Protein Detection using Digital Spatial Profiling: A Technology Designed for Immuno-Oncology Biomarker Discovery and Translational Research -- The InSituPlex Staining Method for Multiplexed Immunofluorescence Cell Phenotyping and Spatial Profiling of Tumor FFPE Samples -- Microbiome as an Immunological Modifier -- Systems Biology for Multi-Platform Data Integration - Overview -- Bioinformatics Tools and Resources for Cancer Immunotherapy Study -- Multiplatform Integrative Analysis of Immunogenomic Data for Biomarker Discovery -- Translating Immuno-Oncology Biomarkers to Diagnostic tests: A regulatory Perspective |
ISBN: | 9781493997732 |
DOI: | 10.1007/978-1-4939-9773-2 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV047302373 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 210528s2020 |||| o||u| ||||||eng d | ||
020 | |a 9781493997732 |9 978-1-4939-9773-2 | ||
024 | 7 | |a 10.1007/978-1-4939-9773-2 |2 doi | |
035 | |a (ZDB-2-PRO)978-1-4939-9773-2 | ||
035 | |a (OCoLC)1190412977 | ||
035 | |a (DE-599)BVBBV047302373 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-91 | ||
082 | 0 | |a 614.5999 | |
245 | 1 | 0 | |a Biomarkers for Immunotherapy of Cancer |b Methods and Protocols |c edited by Magdalena Thurin, Alessandra Cesano, Francesco M. Marincola |
250 | |a 1st ed. 2020 | ||
264 | 1 | |a New York, NY |b Springer New York |c 2020 | |
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Methods in Molecular Biology |v 2055 | |
500 | |a Status of Immune-oncology: Challenges and Opportunities -- Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors -- Measuring Tumor Mutational Burden Using Whole Exome Sequencing -- Germline Genetics in Immuno-Oncology: From Genome-wide to Targeted Biomarker Strategies -- Detection of Microsatellite Instability Biomarkers via Next-generation Sequencing -- Genetic Instability Markers in Cancer -- Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma -- Techniques Associated with Exosome Isolation for Biomarker Development - Liquid Biopsies for Ovarian Cancer Detection -- Identifying MicroRNA Pathway Variants as Biomarkers of Patient Selection for Immune Therapy -- Histone Modifications as Biomarkers for Immunotherapy -- Functional Genome Profiling to Understand Cancer Immune Responsiveness -- Using RNA-sequencing to Characterize the Tumor Microenvironment -- | ||
500 | |a - Development of Gene Expression Based Biomarkers on the nCounter Platform for Immuno-Oncology Applications -- The CRISPR System and Cancer Immunotherapy Biomarkers -- HLA Class I Antigen Processing Machinery Defects in Cancer Cells - Frequency, Functional Significance and Clinical Relevance with Special Emphasis on their Role in T cell-based Immunotherapy of Malignant Disease -- High-parameter Immune Profiling with CyTOF -- The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy -- Single Molecule Arrays for Ultrasensitive Detection of Blood-based Biomarkers for Immunotherapy -- Single-cell Multiplexed Proteomics on the IsoLight Resolves Cellular Functional Heterogeneity to Reveal Clinical Responses of Cancer Patients to Immunotherapies -- Methods to Detect Immunogenic Cell Death in vivo -- Overview of Tissue Imaging Methods -- Multiplex Immunofluorescence Assays -- | ||
500 | |a - Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis -- Cyclic Multiplexed-Immunofluorescence (cmIF), A Highly Multiplexed Method for Single-cell Analysis -- High-Plex Spatially Resolved RNA and Protein Detection using Digital Spatial Profiling: A Technology Designed for Immuno-Oncology Biomarker Discovery and Translational Research -- The InSituPlex Staining Method for Multiplexed Immunofluorescence Cell Phenotyping and Spatial Profiling of Tumor FFPE Samples -- Microbiome as an Immunological Modifier -- Systems Biology for Multi-Platform Data Integration - Overview -- Bioinformatics Tools and Resources for Cancer Immunotherapy Study -- Multiplatform Integrative Analysis of Immunogenomic Data for Biomarker Discovery -- Translating Immuno-Oncology Biomarkers to Diagnostic tests: A regulatory Perspective | ||
520 | |a This book provides the immune oncology (IO) community with a deeper understanding of the scope of the biomarker methods to potentially improve the outcome from immunotherapy. The editors secured the input from experts in the field dedicated to translating scientific research from bench to bedside was submitted. The book provides not only details about the technical, standardization and interpretation aspects of the methods but also introduces the reader to the background information and scientific justification for selected biomarkers and assays. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls | ||
650 | 4 | |a Cancer research | |
650 | 4 | |a Immunology | |
700 | 1 | |a Thurin, Magdalena |e Sonstige |4 oth | |
700 | 1 | |a Cesano, Alessandra |e Sonstige |4 oth | |
700 | 1 | |a Marincola, Francesco M. |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781493997725 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781493997749 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781493997756 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4939-9773-2 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-PRO | ||
940 | 1 | |q ZDB-2-PRO_2020 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-032705524 | ||
347 | |a text file |b PDF | ||
966 | e | |u https://doi.org/10.1007/978-1-4939-9773-2 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1007/978-1-4939-9773-2 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804182483912097792 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
building | Verbundindex |
bvnumber | BV047302373 |
collection | ZDB-2-PRO |
ctrlnum | (ZDB-2-PRO)978-1-4939-9773-2 (OCoLC)1190412977 (DE-599)BVBBV047302373 |
dewey-full | 614.5999 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 614 - Forensic medicine; incidence of disease |
dewey-raw | 614.5999 |
dewey-search | 614.5999 |
dewey-sort | 3614.5999 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
discipline_str_mv | Medizin |
doi_str_mv | 10.1007/978-1-4939-9773-2 |
edition | 1st ed. 2020 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05362nmm a2200505zcb4500</leader><controlfield tag="001">BV047302373</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">210528s2020 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781493997732</subfield><subfield code="9">978-1-4939-9773-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4939-9773-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-4939-9773-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1190412977</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047302373</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614.5999</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biomarkers for Immunotherapy of Cancer</subfield><subfield code="b">Methods and Protocols</subfield><subfield code="c">edited by Magdalena Thurin, Alessandra Cesano, Francesco M. Marincola</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2020</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer New York</subfield><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Molecular Biology</subfield><subfield code="v">2055</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Status of Immune-oncology: Challenges and Opportunities -- Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors -- Measuring Tumor Mutational Burden Using Whole Exome Sequencing -- Germline Genetics in Immuno-Oncology: From Genome-wide to Targeted Biomarker Strategies -- Detection of Microsatellite Instability Biomarkers via Next-generation Sequencing -- Genetic Instability Markers in Cancer -- Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma -- Techniques Associated with Exosome Isolation for Biomarker Development - Liquid Biopsies for Ovarian Cancer Detection -- Identifying MicroRNA Pathway Variants as Biomarkers of Patient Selection for Immune Therapy -- Histone Modifications as Biomarkers for Immunotherapy -- Functional Genome Profiling to Understand Cancer Immune Responsiveness -- Using RNA-sequencing to Characterize the Tumor Microenvironment -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Development of Gene Expression Based Biomarkers on the nCounter Platform for Immuno-Oncology Applications -- The CRISPR System and Cancer Immunotherapy Biomarkers -- HLA Class I Antigen Processing Machinery Defects in Cancer Cells - Frequency, Functional Significance and Clinical Relevance with Special Emphasis on their Role in T cell-based Immunotherapy of Malignant Disease -- High-parameter Immune Profiling with CyTOF -- The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy -- Single Molecule Arrays for Ultrasensitive Detection of Blood-based Biomarkers for Immunotherapy -- Single-cell Multiplexed Proteomics on the IsoLight Resolves Cellular Functional Heterogeneity to Reveal Clinical Responses of Cancer Patients to Immunotherapies -- Methods to Detect Immunogenic Cell Death in vivo -- Overview of Tissue Imaging Methods -- Multiplex Immunofluorescence Assays -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis -- Cyclic Multiplexed-Immunofluorescence (cmIF), A Highly Multiplexed Method for Single-cell Analysis -- High-Plex Spatially Resolved RNA and Protein Detection using Digital Spatial Profiling: A Technology Designed for Immuno-Oncology Biomarker Discovery and Translational Research -- The InSituPlex Staining Method for Multiplexed Immunofluorescence Cell Phenotyping and Spatial Profiling of Tumor FFPE Samples -- Microbiome as an Immunological Modifier -- Systems Biology for Multi-Platform Data Integration - Overview -- Bioinformatics Tools and Resources for Cancer Immunotherapy Study -- Multiplatform Integrative Analysis of Immunogenomic Data for Biomarker Discovery -- Translating Immuno-Oncology Biomarkers to Diagnostic tests: A regulatory Perspective</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book provides the immune oncology (IO) community with a deeper understanding of the scope of the biomarker methods to potentially improve the outcome from immunotherapy. The editors secured the input from experts in the field dedicated to translating scientific research from bench to bedside was submitted. The book provides not only details about the technical, standardization and interpretation aspects of the methods but also introduces the reader to the background information and scientific justification for selected biomarkers and assays. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thurin, Magdalena</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cesano, Alessandra</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marincola, Francesco M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781493997725</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781493997749</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781493997756</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4939-9773-2</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-PRO_2020</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032705524</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-9773-2</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-9773-2</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV047302373 |
illustrated | Not Illustrated |
index_date | 2024-07-03T17:23:44Z |
indexdate | 2024-07-10T09:08:16Z |
institution | BVB |
isbn | 9781493997732 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032705524 |
oclc_num | 1190412977 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
psigel | ZDB-2-PRO ZDB-2-PRO_2020 |
publishDate | 2020 |
publishDateSearch | 2020 |
publishDateSort | 2020 |
publisher | Springer New York |
record_format | marc |
series2 | Methods in Molecular Biology |
spelling | Biomarkers for Immunotherapy of Cancer Methods and Protocols edited by Magdalena Thurin, Alessandra Cesano, Francesco M. Marincola 1st ed. 2020 New York, NY Springer New York 2020 txt rdacontent c rdamedia cr rdacarrier Methods in Molecular Biology 2055 Status of Immune-oncology: Challenges and Opportunities -- Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors -- Measuring Tumor Mutational Burden Using Whole Exome Sequencing -- Germline Genetics in Immuno-Oncology: From Genome-wide to Targeted Biomarker Strategies -- Detection of Microsatellite Instability Biomarkers via Next-generation Sequencing -- Genetic Instability Markers in Cancer -- Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma -- Techniques Associated with Exosome Isolation for Biomarker Development - Liquid Biopsies for Ovarian Cancer Detection -- Identifying MicroRNA Pathway Variants as Biomarkers of Patient Selection for Immune Therapy -- Histone Modifications as Biomarkers for Immunotherapy -- Functional Genome Profiling to Understand Cancer Immune Responsiveness -- Using RNA-sequencing to Characterize the Tumor Microenvironment -- - Development of Gene Expression Based Biomarkers on the nCounter Platform for Immuno-Oncology Applications -- The CRISPR System and Cancer Immunotherapy Biomarkers -- HLA Class I Antigen Processing Machinery Defects in Cancer Cells - Frequency, Functional Significance and Clinical Relevance with Special Emphasis on their Role in T cell-based Immunotherapy of Malignant Disease -- High-parameter Immune Profiling with CyTOF -- The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy -- Single Molecule Arrays for Ultrasensitive Detection of Blood-based Biomarkers for Immunotherapy -- Single-cell Multiplexed Proteomics on the IsoLight Resolves Cellular Functional Heterogeneity to Reveal Clinical Responses of Cancer Patients to Immunotherapies -- Methods to Detect Immunogenic Cell Death in vivo -- Overview of Tissue Imaging Methods -- Multiplex Immunofluorescence Assays -- - Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis -- Cyclic Multiplexed-Immunofluorescence (cmIF), A Highly Multiplexed Method for Single-cell Analysis -- High-Plex Spatially Resolved RNA and Protein Detection using Digital Spatial Profiling: A Technology Designed for Immuno-Oncology Biomarker Discovery and Translational Research -- The InSituPlex Staining Method for Multiplexed Immunofluorescence Cell Phenotyping and Spatial Profiling of Tumor FFPE Samples -- Microbiome as an Immunological Modifier -- Systems Biology for Multi-Platform Data Integration - Overview -- Bioinformatics Tools and Resources for Cancer Immunotherapy Study -- Multiplatform Integrative Analysis of Immunogenomic Data for Biomarker Discovery -- Translating Immuno-Oncology Biomarkers to Diagnostic tests: A regulatory Perspective This book provides the immune oncology (IO) community with a deeper understanding of the scope of the biomarker methods to potentially improve the outcome from immunotherapy. The editors secured the input from experts in the field dedicated to translating scientific research from bench to bedside was submitted. The book provides not only details about the technical, standardization and interpretation aspects of the methods but also introduces the reader to the background information and scientific justification for selected biomarkers and assays. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls Cancer research Immunology Thurin, Magdalena Sonstige oth Cesano, Alessandra Sonstige oth Marincola, Francesco M. Sonstige oth Erscheint auch als Druck-Ausgabe 9781493997725 Erscheint auch als Druck-Ausgabe 9781493997749 Erscheint auch als Druck-Ausgabe 9781493997756 https://doi.org/10.1007/978-1-4939-9773-2 Verlag URL des Erstveröffentlichers Volltext text file PDF |
spellingShingle | Biomarkers for Immunotherapy of Cancer Methods and Protocols Cancer research Immunology |
title | Biomarkers for Immunotherapy of Cancer Methods and Protocols |
title_auth | Biomarkers for Immunotherapy of Cancer Methods and Protocols |
title_exact_search | Biomarkers for Immunotherapy of Cancer Methods and Protocols |
title_exact_search_txtP | Biomarkers for Immunotherapy of Cancer Methods and Protocols |
title_full | Biomarkers for Immunotherapy of Cancer Methods and Protocols edited by Magdalena Thurin, Alessandra Cesano, Francesco M. Marincola |
title_fullStr | Biomarkers for Immunotherapy of Cancer Methods and Protocols edited by Magdalena Thurin, Alessandra Cesano, Francesco M. Marincola |
title_full_unstemmed | Biomarkers for Immunotherapy of Cancer Methods and Protocols edited by Magdalena Thurin, Alessandra Cesano, Francesco M. Marincola |
title_short | Biomarkers for Immunotherapy of Cancer |
title_sort | biomarkers for immunotherapy of cancer methods and protocols |
title_sub | Methods and Protocols |
topic | Cancer research Immunology |
topic_facet | Cancer research Immunology |
url | https://doi.org/10.1007/978-1-4939-9773-2 |
work_keys_str_mv | AT thurinmagdalena biomarkersforimmunotherapyofcancermethodsandprotocols AT cesanoalessandra biomarkersforimmunotherapyofcancermethodsandprotocols AT marincolafrancescom biomarkersforimmunotherapyofcancermethodsandprotocols |